KR860008277A - 프로인슐린-양 물질의 정제방법 - Google Patents

프로인슐린-양 물질의 정제방법 Download PDF

Info

Publication number
KR860008277A
KR860008277A KR1019860002611A KR860002611A KR860008277A KR 860008277 A KR860008277 A KR 860008277A KR 1019860002611 A KR1019860002611 A KR 1019860002611A KR 860002611 A KR860002611 A KR 860002611A KR 860008277 A KR860008277 A KR 860008277A
Authority
KR
South Korea
Prior art keywords
proinsulin
support
impurity
mixture containing
substance
Prior art date
Application number
KR1019860002611A
Other languages
English (en)
Other versions
KR890001243B1 (ko
Inventor
데니스 디마치 리차드
Original Assignee
일라이 릴리 앤드 캄파니
매리 앤 터커
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일라이 릴리 앤드 캄파니, 매리 앤 터커 filed Critical 일라이 릴리 앤드 캄파니
Publication of KR860008277A publication Critical patent/KR860008277A/ko
Application granted granted Critical
Publication of KR890001243B1 publication Critical patent/KR890001243B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

프로인슐린-양 물질의 정제방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 프로인슐린-양 물질을 함유하는 불순 혼합물을 pH 약 7 내지 약 10에서 역상 대공극성 아크길레이트 에스테르 공중합체 수지 지지체에 적용시킨 다음 : 이 지지체로부터 아세톤, 아세토니트릴 및 아세톤과 아세토니트릴의 혼합물중에서 선택한 유기 희석제 약 10용적% 내지 약 30용적%를 함유하는 pH 약 8 내지 약 11의 수성 용출제를 사용하여 프로인슐린-양 물질을 용출시킴을 특징으로 하여, 프로인슐린-양 물질을 함유하는 불순 혼합물로부터 불순물을 분리시키는 방법.
  2. 제1항에 있어서, 프로인슐린-양 물질이 인체 프로인슬린의 아미노산 서열에 상용하는 서열을 갖는 방법.
  3. 제2항에 있어서, 프로인슐린-양 물질이 프로인슐린에 대한 전구체인 방법.
  4. 제3항에 있어서, 프로인슐린-양 물질이 프로인슐린 S-설포네이트인 방법.
  5. 제1 내지 4항중 어느 한 항에 있어서, 대공극성 아크릴레이트 에스테르 공중합체 지지체가 XAD-7 또는 XAD-8인 방법.
  6. 제5항에 있어서, 프로인슐린-양 물질을 함유하는 불순 혼합물을 뱃치 조건하에서 처리하는 방법.
  7. 제5항에 있어서, 프로인슐린-양 물질을 함유하는 불순 혼합물을 크로마토그래피 칼럼 조건하에서 처리하는 방법.
  8. 제5항에 있어서, 프로인슐린-양 물질을 함유하는 불순 혼합물을 pH 약 8 내지 약 9에서 대공극성 아크킬레이트 에스테르 공중합체 지지체에 적용시키는 방법.
  9. 제8항에 있어서, 불순 혼합물을 지지체에 적용시킨 후, 용출시키기 전에 지지체를 pH 약 7 내지 약 8.5의 수성 완충액으로 세척하는 방법.
  10. 제9항에 있어서, 프로인슐린-양 물질을 pH 약 10.5의 수성 용출제를 사용하여 지지체로부터 용출시키는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860002611A 1985-04-08 1986-04-07 프로인슐린-양 물질의 정제방법 KR890001243B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US720,641 1985-04-08
US06/720,641 US4616078A (en) 1985-04-08 1985-04-08 Process for purifying proinsulin-like materials
US720641 1985-04-08

Publications (2)

Publication Number Publication Date
KR860008277A true KR860008277A (ko) 1986-11-14
KR890001243B1 KR890001243B1 (ko) 1989-04-28

Family

ID=24894751

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860002611A KR890001243B1 (ko) 1985-04-08 1986-04-07 프로인슐린-양 물질의 정제방법

Country Status (12)

Country Link
US (1) US4616078A (ko)
EP (1) EP0197764B1 (ko)
JP (1) JPH0796559B2 (ko)
KR (1) KR890001243B1 (ko)
AT (1) ATE91690T1 (ko)
AU (1) AU593242B2 (ko)
CA (1) CA1284249C (ko)
DE (1) DE3688712T2 (ko)
DK (1) DK173414B1 (ko)
HU (1) HU205138B (ko)
IE (1) IE60570B1 (ko)
IL (1) IL78373A (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
DK340189D0 (da) * 1989-07-10 1989-07-10 Jens Villadsens Fabrikker A S Fremgangsmaade til fremstilling af en fuldklaebet belaegning paa et underlag
US5071560A (en) * 1989-07-17 1991-12-10 Uop Process for purifying phenylalanine
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
US7741536B2 (en) 1997-08-07 2010-06-22 University Of Central Florida Research Foundation, Inc. Expression of human serum albumin in plastids
US20030204864A1 (en) * 2001-02-28 2003-10-30 Henry Daniell Pharmaceutical proteins, human therapeutics, human serum albumin, insulin, native cholera toxic b submitted on transgenic plastids
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
CN1305589A (zh) * 1998-04-17 2001-07-25 基因创新有限公司 采用还原剂的改进型免疫诊断分析
US20100251425A9 (en) 1998-05-15 2010-09-30 University Of Central Florida Expression of human interferon in transgenic chloroplasts
DE19838097A1 (de) * 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
EP1274846A4 (en) * 2000-03-01 2004-09-29 Univ Auburn PLASTIDE TRANSFORMATION VECTOR FOR THE EXPRESSION OF HUMAN PROTEINS IN PLANTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649456A (en) * 1969-09-08 1972-03-14 Rohm & Haas Separation of polypeptide substances with macroreticular resins
US3907676A (en) * 1970-07-28 1975-09-23 Novo Terapeutisk Labor As Process for purifying insulin
US3876623A (en) * 1973-05-09 1975-04-08 Lilly Co Eli Process for purifying insulin
AU5397579A (en) * 1978-12-26 1980-07-03 Eli Lilly And Company Purifying insulin
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor

Also Published As

Publication number Publication date
HUT40680A (en) 1987-01-28
DK173414B1 (da) 2000-10-02
HU205138B (en) 1992-03-30
JPS61236796A (ja) 1986-10-22
IL78373A0 (en) 1986-07-31
DK150586A (da) 1986-10-09
KR890001243B1 (ko) 1989-04-28
DE3688712T2 (de) 1993-11-25
IE860887L (en) 1986-10-08
EP0197764A3 (en) 1988-08-31
DK150586D0 (da) 1986-04-03
CA1284249C (en) 1991-05-14
EP0197764B1 (en) 1993-07-21
IL78373A (en) 1990-07-12
JPH0796559B2 (ja) 1995-10-18
AU593242B2 (en) 1990-02-08
US4616078A (en) 1986-10-07
AU5565586A (en) 1986-10-16
DE3688712D1 (de) 1993-08-26
IE60570B1 (en) 1994-07-27
EP0197764A2 (en) 1986-10-15
ATE91690T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
KR860008277A (ko) 프로인슐린-양 물질의 정제방법
KR830000910A (ko) 정제된 프로테인 및 정제방법
MX9707909A (es) Purificacion de anticuerpos.
NO176570C (no) Proteinmateriale, inhibin, fremgangsmåte for renfremstilling av dette, antistoff mot inhibin, ikke-terapeutiske blandinger inneholdende inhibin/antistoff samt anvendelse for diagnostiske og analytiske formål
ES2155477T3 (es) Purificacion cromatografica y procedimiento de separacion de acidos nucleicos.
DE3064133D1 (en) Purification of human growth hormone
EP0390577A3 (en) Purification and preparation processes for methyl methacrylate
KR960022971A (ko) 들깨유로부터 α-리놀렌산(ALA)을 분리, 정제하는 방법
AU3137699A (en) Novel process for the separation of proteins using a Ca ++ containing eluant
KR860008278A (ko) 성장 호르몬-양 물질의 정제방법
EP0216936A4 (en) NEW TANNIN COMPOSITION.
Wachtel et al. Chromatography as a Means of Separating Amino Acids1
DE3363641D1 (en) Process for purifying secretin
EP0359322A3 (en) Liquid chromatography
Hearn et al. The Analysis of Insulin-Related Peptides by Reversed-Phase High-Performance Liquid Chromatography
Humbel et al. Chromatographic separation of aminoethylated insulin A and B chains
EP0256840A3 (en) Process for separation of acids and corresponding acid metal salts
Dillon et al. HETEROGENEITY OF INSULIN: I. ISOLATION OF A CHROMATOGRAPHICALLY PURIFIED, HIGH-POTENCY INSULIN AND SOME OF ITS PROPERTIES
KR860009034A (ko) 핵산 정제모액의 처리방법
RU98123499A (ru) Способ очистки сырого продукта, содержащего циклоспориновый комплекс, циклоспорин а высокой чистоты и способ промышленного масштаба для очистки циклоспорина а
GB1285024A (en) Process of purifying insulin
ATE198600T1 (de) Verfahren zur reinigung von 11beta-21-dihydroxy- 2'-methyl-5'-betah-pregna-1,4-dieno(17,16-d)- oxazole-3, 20-dione
CA1264148C (en) HYDROXYPALATITE FOR THE ANALYSIS AND PREPARATION OF PURIFIED MONOCLONAL ANTIBODIES
DK346682A (da) Fremgangsmaade til fremstilling af polypeptidderivater
JPS5340712A (en) Isolation and purification of alpha-and omega-isomers of acidic amino acid or peptide having acidic amino acid unit

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19860407

PA0201 Request for examination
PG1501 Laying open of application
G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19890314

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19890724

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19890808

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19890808

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19920427

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19930329

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19940317

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19950323

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19960329

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19970319

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19980403

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19990310

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20000329

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20010406

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20020404

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20030331

Start annual number: 15

End annual number: 15

FPAY Annual fee payment

Payment date: 20040412

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20040412

Start annual number: 16

End annual number: 16

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee